Rockefeller Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $463M | Buy |
503,731
+47,158
| +10% | +$47.8M | 0.82% | 17 |
|
|
2025
Q4 | $491M | Buy |
456,573
+23,642
| +5% | +$22.6M | 0.88% | 17 |
|
|
2025
Q3 | $330M | Buy |
432,931
+3,248
| +0.8% | +$2.42M | 0.65% | 19 |
|
|
2025
Q2 | $335M | Buy |
429,683
+32,393
| +8% | +$25.2M | 0.73% | 18 |
|
|
2025
Q1 | $328M | Buy |
397,290
+21,266
| +6% | +$17.7M | 0.81% | 18 |
|
|
2024
Q4 | $290M | Sell |
376,024
-102,996
| -22% | -$85.3M | 0.75% | 19 |
|
|
2024
Q3 | $424M | Sell |
479,020
-47,459
| -9% | -$42.7M | 1.14% | 10 |
|
|
2024
Q2 | $477M | Sell |
526,479
-3,920
| -0.7% | -$3.14M | 1.35% | 9 |
|
|
2024
Q1 | $413M | Buy |
530,399
+14,038
| +3% | +$9.99M | 1.2% | 9 |
|
|
2023
Q4 | $301M | Buy |
516,361
+6,758
| +1% | +$3.94M | 1.01% | 11 |
|
|
2023
Q3 | $274M | Sell |
509,603
-32,065
| -6% | -$16.5M | 1.06% | 9 |
|
|
2023
Q2 | $254M | Sell |
541,668
-46,871
| -8% | -$19.7M | 0.98% | 10 |
|
|
2023
Q1 | $202M | Buy |
588,539
+58,445
| +11% | +$19.7M | 0.87% | 12 |
|
|
2022
Q4 | $194M | Sell |
530,094
-215,319
| -29% | -$76.3M | 0.97% | 10 |
|
|
2022
Q3 | $241M | Sell |
745,413
-18,409
| -2% | -$5.83M | 1.25% | 5 |
|
|
2022
Q2 | $248M | Buy |
763,822
+22,068
| +3% | +$6.62M | 1.32% | 5 |
|
|
2022
Q1 | $212M | Sell |
741,754
-21,547
| -3% | -$5.55M | 1.02% | 9 |
|
|
2021
Q4 | $211M | Buy |
763,301
+93,969
| +14% | +$23.8M | 0.98% | 9 |
|
|
2021
Q3 | $155M | Buy |
669,332
+13,597
| +2% | +$3.36M | 0.81% | 18 |
|
|
2021
Q2 | $151M | Buy |
655,735
+15,320
| +2% | +$3.08M | 0.85% | 14 |
|
|
2021
Q1 | $120M | Buy |
640,415
+541,706
| +549% | +$106M | 0.81% | 21 |
|
|
2020
Q4 | $16.7M | Buy |
98,709
+29,690
| +43% | +$4.43M | 0.13% | 178 |
|
|
2020
Q3 | $10.2M | Buy |
69,019
+12,548
| +22% | +$1.94M | 0.1% | 202 |
|
|
2020
Q2 | $9.27M | Buy |
56,471
+92
| +0.2% | +$14.1K | 0.1% | 189 |
|
|
2020
Q1 | $7.82M | Buy |
56,379
+3,372
| +6% | +$463K | 0.1% | 181 |
|
|
2019
Q4 | $6.97M | Buy |
53,007
+10,536
| +25% | +$1.22M | 0.09% | 185 |
|
|
2019
Q3 | $4.75M | Buy |
42,471
+28,311
| +200% | +$3.15M | 0.06% | 202 |
|
|
2019
Q2 | $1.57M | Sell |
14,160
-2,822
| -17% | -$332K | 0.02% | 283 |
|
|
2019
Q1 | $2.2M | Sell |
16,982
-5,067
| -23% | -$616K | 0.03% | 245 |
|
|
2018
Q4 | $2.55M | Buy |
22,049
+17,090
| +345% | +$1.91M | 0.04% | 167 |
|
|
2018
Q3 | $532K | Hold |
4,959
| – | – | 0.01% | 280 |
|
|
2018
Q2 | $423K | Buy |
4,959
+191
| +4% | +$15.7K | 0.01% | 286 |
|
|
2018
Q1 | $369K | Buy |
+4,768
| New | +$384K | 0.01% | 293 |
|
Other funds holding LLY
VCM
VPM
Rockefeller Capital Management's LLY Position: Q1 2026 in Review
Rockefeller Capital Management increased its Eli Lilly (LLY) stake by 10% in Q1 2026, buying an estimated $47.8M and bringing the position to 503,731 shares worth $463M. The position accounts for 0.82% of the portfolio, ranked #17.
Rockefeller Capital Management first reported a position in LLY in Q1 2018 and has held it in 33 quarters since. The position peaked at $491M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Rockefeller Capital Management held 503,731 shares of Eli Lilly worth $463M as of Q1 2026.
- Rockefeller Capital Management bought 47,158 Eli Lilly shares in Q1 2026, an estimated $47.8M.
- Eli Lilly made up 0.82% of Rockefeller Capital Management's portfolio in Q1 2026, its #17 holding.
- Rockefeller Capital Management first reported a position in Eli Lilly in Q1 2018 and has held it in 33 quarters since.
- Rockefeller Capital Management's Eli Lilly position peaked at $491M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Rockefeller Capital Management's 13F filing for Q1 2026, filed 14 May 2026.